Abstract:Background: For the management of hemolytic disease of the fetus and newborn (HDFN), it is important to detect unexpected red cell antibody in pregnant women. We assessed the prevalence of unexpected red cell antibodies in consecutive pregnant women attending antenatal clinic (ANC). More importantly, cases with unexpected antibody causing severe anemia were followed-up for intervention (Intra-uterine transfusion {IUT}) and outcome of pregnancy (still-birth/live-healthy). Aims and objectives: The study was conducted with an objective to find the prevalence of unexpected RBC antibodies in pregnant women, their specificity and to do the follow-up for IUT and outcome of pregnancy (still-birth, live-birth) in antibody positive women. Materials and methods: This was a prospective study from January 2021 to May 2022 at two tertiary care centres. All antenatal samples received by the laboratory were screened for unexpected red cell antibody. Whenever antibody screen was positive, antibody identification was performed. Patients, positive for unexpected antibody and anemia were followed up for any transfusion-based intervention and outcome of pregnancy. Results: A total of 539 consecutive samples were worked up and among these, 10 samples (1.85%) were found to be antibody positive. The antibodies identified were Anti-D (n=6), anti-Leb (n=1), anti-M (n=1), anti-C (n=1) and anti-E (n=1).The prevalence of unexpected antibodies in Rh positive and Rh negative pregnant women was 0.83% and 10.9% respectively. Follow-up was done for all 10 cases with unexpected antibody and anemia was monitored by MCA PSV (middle cerebral artery peak systolic velocity).Two women developed severe anemia thus requiring single intrauterine transfusion (at 26 weeks and 28 weeks respectively) each, for correction of anemia. In both these cases, healthy male child was delivered. At 3-month follow-up both children were alive and healthy. Conclusion: The study found prevalence of unexpected RBC antibodies in pregnant women as 1.85%. The study also underlined importance of transfusion-based interventions contributing to successful outcome in couple of cases with severe anemia.

[Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].

Clinical Significance of Screening of Rh-negative Blood Group and Detection of Irregular Antibody

[Immunoserology and RHD Genotype Analysis of DVI Type 3 Genotype Pregnant Women with Anti-D].

Application of anti-D immunoglobulin in D-negative pregnant women in China

Analysis of Perinatal Outcomes in Sensitized Pregnant Women with RhD-negative Blood Type without Passive Immunotherapy

Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D- pregnant women

Research on RhD Genotype of Maternity with RhD Negative

Few points on anti-D immunoglobulin administration in Rh-negative pregnant women

Clinical Characteristics and Prognosis of Hemolytic Disease of the Newborn Caused by Irregular Antibodies: A 13-Year Retrospective Analysis

Hemolytic Diseases of the Fetus and Newborn Caused by Anti-Dib: a Case Report and Related Research

DEL phenotype screening and genotypic analysis of 100 first-screen RhD-negative pregnant women

High-throughput Genotyping Multiplex Ligation-Dependent Probe Amplification for Assisting Diagnosis in a Case of Anti-Dia-induced Severe Hemolytic Disease of the Newborn

[Investigation and Analysis of Non-ABO Hemolytic Disease of the Newborn]

'Old is gold' does conventional test tube method still reign supreme? An immuno‐haematological survey of anti‐D detection and titration in ante‐natal cases among major hospitals across India

Another piece of the hemolytic disease of the fetus and newborn puzzle after RhD-positive transfusion in trauma resuscitation: the proportion of pregnant women who produce high titer anti-D

Identification of pregnant women with DFR genotype and discussion of prenatal examination strategy

Antenatal Detection of Anti-D is Unnecessary for DEL Women

Prevalence of unexpected red blood cell antibodies in pregnant women and follow-up of pregnancy outcome in pregnant women treated with intra-uterine transfusion

Why do RhD negative pregnant women still become anti-D immunized despite prophylaxis with anti-D immunoglobulin?

Noninvasive screening of fetal RHD genotype in Chinese pregnant women with serologic RhD-negative phenotype.

[Retrospective Analysis of Irregular Antibodies Causing Hemolytic Disease of the Fetus and Newborn in Jiangxi Province]